Internal profit and loss account
| Internal profit and loss account | 1.1.–31.12.2024 | 1.1.–31.12.2023 |
|---|---|---|
| NET TURNOVER | 57 184 400,28 | 57 400 907,56 |
| Variation in stocks of finished goods and in work in progress | 201 784,38 | -19 355,00 |
| Other operational income | 1 668 428,16 | 1 764 499,02 |
| Raw materials and services | ||
| Raw materials and consumables | ||
| Purchases during the financial year | 12 469 753,93 | 11 433 116,81 |
| Variation in stocks | -428 508,00 | 175 879,00 |
| External services | 2 863 318,98 | 2 569 088,18 |
| Raw materials and services, total | 14 904 564,91 | 14 178 083,99 |
| Staff expenses | ||
| Wages and salaries | 23 112 207,37 | 22 672 846,05 |
| Social security expenses | ||
| Pension expenses | 3 904 634,96 | 4 056 622,62 |
| Other social security expenses | 533 108,87 | 841 159,79 |
| Staff expenses, total | 27 549 951,20 | 27 570 628,46 |
| Depreciation, amortisation and reduction in value | ||
| Reduction in value | 481 096,91 | |
| Depreciation and amortisation according to plan | 3 597 246,40 | 3 542 652,82 |
| Depreciation, amortisation and reduction in value, total | 4 078 343,31 | 3 542 652,82 |
| Other operating expenses | 18 499 045,78 | 17 921 707,25 |
| OPERATING PROFIT/LOSS | -5 977 292,38 | -4 067 020,94 |
| Financial income and expenses | ||
| Interest income and other financial income | 2 596 661,30 | 1 265 941,70 |
| Interest and other financial expenses | -53 550,23 | -169 127,24 |
| Financial income and expenses, total | 2 543 111,07 | 1 096 814,46 |
| Change in value | 3 364 304,05 | 3 507 897,68 |
| PROFIT/LOSS BEFORE APPROPRIATIONS | -69 877,26 | 537 691,20 |
| Taxes | ||
| Blood Service Research Fund | -500 000,00 | -497 248,86 |
| PROFIT/LOSS FOR THE FINANCIAL YEAR (internal) | -569 877,26 | 40 442,34 |